Kronos Worldwide (KRO) 10-Q 7 Nov 14 2014 Q3 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	9 Months Ended
	Sep. 30, 2014	Oct. 31, 2014
Document Document And Entity Information [Abstract]	'	'
Document Type	'10-Q	'
Amendment Flag	'false	'
Document Period End Date	30-Sep-14	'
Document Fiscal Year Focus	'2014	'
Document Fiscal Period Focus	'Q3	'
Trading Symbol	'KRO	'
Entity Registrant Name	'KRONOS WORLDWIDE INC	'
Entity Central Index Key	'0001257640	'
Current Fiscal Year End Date	'--12-31	'
Entity Filer Category	'Accelerated Filer	'
Entity Common Stock, Shares Outstanding	'	115,872,598

CONDENSED_CONSOLIDATED_BALANCE

CONDENSED CONSOLIDATED BALANCE SHEETS (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Current assets:	'	'
Cash and cash equivalents	$151.20	$53.80
Restricted cash	2	2.6
Accounts and other receivables	329.9	282.5
Inventories, net	399.6	416.6
Prepaid expenses and other	10.8	9.1
Deferred income taxes	4.1	16.6
Total current assets	897.6	781.2
Other assets:	'	'
Investment in TiO2 manufacturing joint venture	89.1	102.3
Marketable securities	11.3	30.4
Deferred income taxes	135.8	148.4
Other	16.8	20.5
Total other assets	253	301.6
Property and equipment:	'	'
Land	45.1	46.3
Buildings	230.6	242.7
Equipment	1,080.60	1,122.80
Mining properties	127.8	130.1
Construction in progress	37.1	50
Gross property and equipment	1,521.20	1,591.90
Less accumulated depreciation and amortization	1,020.40	1,055.60
Net property and equipment	500.8	536.3
Total assets	1,651.40	1,619.10
Current liabilities:	'	'
Current maturities of long-term debt	3.9	3.1
Accounts payable and accrued liabilities	205.2	264
Income taxes	0.3	8.9
Deferred income taxes	1.9	2
Total current liabilities	211.3	278
Noncurrent liabilities:	'	'
Long-term debt	345.7	180.4
Deferred income taxes	11	19.5
Accrued pension cost	144.5	163.8
Accrued postretirement benefits cost	7.5	7.8
Other	30.5	34.5
Total noncurrent liabilities	539.2	406
Stockholders' equity:	'	'
Common stock	1.2	1.2
Additional paid-in capital	1,398.60	1,398.50
Retained deficit	-285.4	-312.6
Accumulated other comprehensive loss	-213.5	-152
Total stockholders' equity	900.9	935.1
Total liabilities and stockholders' equity	1,651.40	1,619.10
Commitments and contingencies (Notes 8 and 12)	'	'

CONDENSED_CONSOLIDATED_STATEME

CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS (USD $)	3 Months Ended		9 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Statement [Abstract]	'	'	'	'
Net sales	$414.80	$419.10	$1,278.40	$1,363.80
Cost of sales	319.1	371.9	1,008.40	1,303.10
Gross margin	95.7	47.2	270	60.7
Selling, general and administrative expense	47.7	44.7	145.9	143.4
Other operating income (expense):	'	'	'	'
Currency transaction gains (losses), net	2.9	-0.3	2.8	-1.4
Other operating expense, net	-3	-39.2	-8.7	-47.5
Income (loss) from operations	47.9	-37	118.2	-131.6
Other income (expense):	'	'	'	'
Interest and dividend income	0.2	0.3	0.7	0.9
Loss on prepayment of debt, net	'	-2.3	'	-8.9
Interest expense	-3.9	-4.5	-12.6	-16.6
Income (loss) before income taxes	44.2	-43.5	106.3	-156.2
Income tax expense (benefit)	12.3	-13.6	27	-51.3
Net income (loss)	$31.90	($29.90)	$79.30	($104.90)
Net income (loss) per basic and diluted share	$0.28	($0.26)	$0.68	($0.91)
Cash dividends per share	$0.15	$0.15	$0.45	$0.45
Weighted average shares used in the calculation of net income (loss) per share	115.9	115.9	115.9	115.9

CONDENSED_CONSOLIDATED_STATEME1

CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Net income (loss)	$31.90	($29.90)	$79.30	($104.90)
Other comprehensive income (loss), net of tax:	'	'	'	'
Marketable securities	'	8.2	-13.2	9.4
Currency translation	-46.7	21	-53.6	-0.6
Total other comprehensive income (loss), net	-45	31.6	-61.5	16.1
Comprehensive income (loss)	-13.1	1.7	17.8	-88.8
Defined Benefit Pension Plans	'	'	'	'
Other comprehensive income (loss), net of tax:	'	'	'	'
Defined benefit plans	1.9	2.4	5.7	7.4
OPEB	'	'	'	'
Other comprehensive income (loss), net of tax:	'	'	'	'
Defined benefit plans	($0.20)	'	($0.40)	($0.10)

CONDENSED_CONSOLIDATED_STATEME2

CONDENSED CONSOLIDATED STATEMENT OF STOCKHOLDERS' EQUITY (USD $)	Total	Common stock	Additional paid-in capital	Retained earnings (deficit)	Accumulated other comprehensive loss
In Millions
Beginning Balance at Dec. 31, 2013	$935.10	$1.20	$1,398.50	($312.60)	($152)
Net income	79.3	'	'	79.3	'
Other comprehensive loss, net of tax	-61.5	'	'	'	-61.5
Issuance of common stock	0.1	'	0.1	'	'
Dividends paid	-52.1	'	'	-52.1	'
Ending Balance at Sep. 30, 2014	$900.90	$1.20	$1,398.60	($285.40)	($213.50)

CONDENSED_CONSOLIDATED_STATEME3

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013
Cash flows from operating activities:	'	'
Net income (loss)	$79.30	($104.90)
Depreciation and amortization	37.6	37.6
Deferred income taxes	20.6	-62.1
Loss on prepayment of debt, net	'	8.9
Benefit plan expense greater than cash funding	0.1	2.5
Distributions from TiO2 manufacturing joint venture, net	13.2	4
Other, net	2.3	5.1
Change in assets and liabilities:	'	'
Accounts and other receivables	-77.2	-37.3
Inventories	-7.1	242.9
Prepaid expenses	-2.5	-3
Accounts payable and accrued liabilities	-40.2	16
Income taxes	-1.9	-8.8
Accounts with affiliates	5	-40.7
Other, net	-2.7	0.6
Net cash provided by operating activities	26.5	60.8
Cash flows from investing activities:	'	'
Capital expenditures	-39.9	-49.9
Change in restricted cash, net	7.5	0.6
Other, net	'	-0.1
Net cash used in investing activities	-32.4	-49.4
Indebtedness:	'	'
Borrowings	430.4	294.8
Principal payments	-264.3	-476.5
Deferred financing fees	-6.1	'
Dividends paid	-52.1	-52.2
Treasury stock acquired	'	-0.7
Net cash provided by (used in) financing activities	107.9	-234.6
Cash and cash equivalents - net change from:	'	'
Operating, investing and financing activities	102	-223.2
Currency translation	-4.6	0.3
Balance at beginning of period	53.8	282.7
Balance at end of period	151.2	59.8
Supplemental disclosures b Cash paid for:	'	'
Interest, net of capitalized interest	10.8	15.6
Income taxes	19.7	33.6
Accrual for capital expenditures	$5.60	$3.70

Organization_and_Basis_of_Pres

Organization and Basis of Presentation	9 Months Ended
	Sep. 30, 2014
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'
Organization and Basis of Presentation	'
	Note 1 - Organization and basis of presentation:
	Organization - At September 30, 2014, (i) Valhi, Inc. (NYSE: VHI) held approximately 50% of our outstanding common stock (ii) NL Industries, Inc. (NYSE: NL) held approximately 30% of our common stock, (iii) Valhi owned approximately 83% of NL’s outstanding common stock and (iv) a wholly-owned subsidiary of Contran Corporation held approximately 94% of Valhi’s outstanding common stock.  Substantially all of Contran’s outstanding voting stock is held by family trusts established for the benefit of Lisa K. Simmons and Serena Simmons Connelly, daughters of Harold C. Simmons, and their children (for which Ms. Lisa Simmons and Ms. Connelly are co-trustees) or is held directly by Ms. Lisa Simmons and Ms. Connelly or persons or entities related to them, including their step-mother Annette C. Simmons, the widow of Mr. Simmons. Prior to his death in December 2013, Mr. Simmons served as sole trustee of the family trusts.  Under a voting agreement entered into by all of the voting stockholders of Contran, effective in February 2014 and as amended, the size of the board of directors of Contran was fixed at five members, Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons (and in the event of their death, their heirs) each has the right to designate one of the five members of the Contran board and the remaining two members of the Contran board must consist of members of Contran management. Ms. Lisa Simmons, Ms. Connelly, and Ms. Annette Simmons each serve as members of the Contran board.  The voting agreement expires in February 2017 (unless Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons otherwise unanimously agree), and the ability of Ms. Lisa Simmons, Ms. Connelly, and Ms. Annette Simmons to each designate one member of the Contran board is dependent upon each of their continued beneficial ownership of at least 5% of the combined voting stock of Contran.  Consequently, Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons may be deemed to control Contran, Valhi, NL and us.
	Basis of presentation - The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2013 that we filed with the Securities and Exchange Commission (SEC) on March 12, 2014 (2013 Annual Report).  In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented.  We have condensed the Consolidated Balance Sheet and Statement of Stockholders’ Equity at December 31, 2013 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2013) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP).  Our results of operations for the interim periods ended September 30, 2014 may not be indicative of our operating results for the full year.  The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2013 Consolidated Financial Statements contained in our 2013 Annual Report.
	Unless otherwise indicated, references in this report to “we,” “us” or “our” refer to Kronos Worldwide, Inc. and its subsidiaries (NYSE: KRO) taken as a whole.

Accounts_and_Other_Receivables

Accounts and Other Receivables	9 Months Ended
	Sep. 30, 2014
Receivables [Abstract]	'
Accounts and Other Receivables	'
	Note 2 - Accounts and other receivables:
		December 31,			September 30,
		2013			2014
		(In millions)
	Trade receivables	$	226.1		$	288.4
	Receivable from affiliates:
	Louisiana Pigment Company, L.P.		14.2			-
	Income taxes, net - Valhi		-			5.8
	Other		-			1.2
	Recoverable VAT and other receivables		28.3			27.6
	Refundable income taxes		14.9			7.9
	Allowance for doubtful accounts		(1.0	)		(1.0	)
	Total	$	282.5		$	329.9

Inventories_Net

Inventories, Net	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Inventories, Net	'
	Note 3 - Inventories, net:
		December 31,		September 30,
		2013		2014
		(In millions)
	Raw materials	$	66.6	$	62.2
	Work in process		18		28.6
	Finished products		262.6		242.1
	Supplies		69.4		66.7
	Total	$	416.6	$	399.6

Marketable_Securities

Marketable Securities	9 Months Ended
	Sep. 30, 2014
Investments Debt And Equity Securities [Abstract]	'
Marketable Securities	'
	Note 4 - Marketable securities:
	Our marketable securities consist of investments in the publicly-traded shares of related parties: Valhi, NL and CompX International Inc. NL owns a majority of CompX’s outstanding common stock.  All of our marketable securities are accounted for as available-for-sale securities, which are carried at fair value using quoted market prices in active markets for each marketable security, and represent a Level 1 input within the fair value hierarchy.  See Note 13.  Because we have classified all of our marketable securities as available-for-sale, any unrealized gains or losses on the securities are recognized through other comprehensive income, net of deferred income taxes.
		Fair value
		measurement	Market		Cost		Unrealized
	Marketable security	level	value		basis		gain (loss)
			(In millions)
	31-Dec-13
	Valhi common stock	1	$	30.3	$	15.3	$	15
	NL and CompX common stocks	1		0.1		0.1		-
	Total		$	30.4	$	15.4	$	15
	30-Sep-14
	Valhi common stock	1	$	11.2	$	15.3	$	(4.1	)
	NL and CompX common stocks	1		0.1		0.1		-
	Total		$	11.3	$	15.4	$	(4.1	)
	At December 31, 2013 and September 30, 2014, we held approximately 1.7 million shares of Valhi’s common stock which we purchased during 2010 and 2011.  We also held a nominal number of shares of CompX and NL common stocks.  At December 31, 2013 and September 30, 2014, the quoted per share market price of Valhi’s common stock was $17.58 and $6.53, respectively.
	The Valhi, CompX and NL common stocks we own are subject to the restrictions on resale pursuant to certain provisions of SEC Rule 144.  In addition, as a majority-owned subsidiary of Valhi we cannot vote our shares of Valhi common stock under Delaware Corporation Law, but we do receive dividends from Valhi on these shares, when declared and paid.
	With respect to our investment in Valhi stock, our cost basis has exceeded its market value since March 2014, but we consider such decline in market price to be temporary at September 30, 2014.  We considered all available evidence in reaching this conclusion, including our ability and intent to hold this investment for a reasonable period of time sufficient for the recovery of fair value, as evidenced by the amount of liquidity we currently have with cash on hand.  We will continue to monitor the quoted market price for this investment.  In this regard, as of October 31, 2014, the aggregate quoted market price for our shares of Valhi common stock was $5.1 million less than our aggregate cost basis.  If we conclude in the future that a decline in value of one or more of these securities was other than temporary, we would recognize impairment through an income statement charge at that time.  Such income statement impairment charge would be offset in other comprehensive income by the reversal of the previously recognized unrealized losses to the extent they were previously recognized in accumulated other comprehensive income.

Other_Noncurrent_Assets

Other Noncurrent Assets	9 Months Ended
	Sep. 30, 2014
Assets Noncurrent [Abstract]	'
Other Noncurrent Assets	'
	Note 5 - Other noncurrent assets:
		December 31,		September 30,
		2013		2014
		(In millions)
	Deferred financing costs, net	$	2.5	$	7.2
	Restricted cash		7.4		0.3
	Pension asset		0.2		0.4
	Other		10.4		8.9
	Total	$	20.5	$	16.8

Accounts_Payable_and_Accrued_L

Accounts Payable and Accrued Liabilities	9 Months Ended
	Sep. 30, 2014
Payables And Accruals [Abstract]	'
Accounts Payable and Accrued Liabilities	'
	Note 6 - Accounts payable and accrued liabilities:
		December 31,		September 30,
		2013		2014
		(In millions)
	Accounts payable	$	123.9	$	105.1
	Employee benefits		26.7		29.5
	Accrued sales discounts and rebates		16.7		19.5
	Reserve for uncertain tax positions		3.1		-
	Accrued interest		0.1		0.5
	Accrued legal settlement		35		-
	Payables to affiliates:
	Louisiana Pigment Company, L.P.		21.1		15.3
	Income taxes, net - Valhi		0.5		-
	Other		0.1		-
	Other		36.8		35.3
	Total	$	264	$	205.2

LongTerm_debt

Long-Term debt	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Long-Term Debt	'
	Note 7 - Long-term debt:
		December 31,		September 30,
		2013		2014
		(In millions)
	Term loan	$	-	$	346.7
	Note payable to Contran		170		-
	Revolving North American credit facility		11.1		-
	Other		2.4		2.9
	Total debt		183.5		349.6
	Less current maturities		3.1		3.9
	Total long-term debt	$	180.4	$	345.7
	Term loan - In February 2014, we entered into a new $350 million term loan. The term loan was issued at 99.5% of the principal amount, or an aggregate of $348.25 million.  We used $170 million of the net proceeds of the new term loan to prepay the outstanding principal balance of our note payable to Contran (along with accrued and unpaid interest through the prepayment date), and such note payable was cancelled. The remaining net proceeds of the term loan are available for our general corporate purposes. The new term loan:
	—	bears interest, at our option, at LIBOR (with LIBOR no less than 1.0%) plus 3.75%, or the base rate, as defined in the agreement, plus 2.75%;
	—	requires quarterly principal repayments of $875,000 which commenced in June 2014, other mandatory principal repayments of formula-determined amounts under specified conditions with all remaining principal balance due in February 2020. Voluntary principal prepayments are permitted at any time, provided that a call premium of 1% of the principal amount of such prepayment applies to any voluntary prepayment made on or before February 2015 (there is no prepayment penalty applicable to any voluntary prepayment after February 2015);
	—	is collateralized by, among other things, a first priority lien on (i) 100% of the common stock of certain of our U.S. wholly-owned subsidiaries, (ii) 65% of the common stock or other ownership interest of our Canadian subsidiary (Kronos Canada, Inc.) and certain first-tier European subsidiaries (Kronos Titan GmbH and Kronos Denmark ApS) and (iii) a $395.7 million unsecured promissory note issued by our wholly-owned subsidiary, Kronos International, Inc. (KII) to us;
	—	is also collateralized by a second priority lien on all of the U.S. assets which collateralize our North American revolving facility;
	—	contains a number of covenants and restrictions which, among other things, restrict our ability to incur additional debt, incur liens, pay dividends or merge or consolidate with, or sell or transfer substantially all of our assets to, another entity, contains other provisions and restrictive covenants customary in lending transactions of this type (however, there are no ongoing financial maintenance covenants); and
	—	contains customary default provisions, including a default under any of our other indebtedness in excess of $50 million.
	The average interest rate on the term loan borrowings as of and for the period from issuance to September 30, 2014 was 4.75%. The carrying value of the term loan at September 30, 2014 includes unamortized original issue discount of $1.6 million.
	In 2013, we voluntarily repaid our entire $400 million term loan that was issued in June 2012. We prepaid an aggregate $290 million principal amount in February 2013 and we recognized a non-cash pre-tax interest charge of $6.6 million in the first quarter of 2013 related to this prepayment consisting of the write-off of unamortized original issue discount costs and deferred financing costs associated with such prepayment. Funds for such $290 million prepayment were provided by $100 million of our cash on hand as well as borrowings of $190 million under a 2013 loan agreement from Contran as described below. In July 2013, we voluntarily prepaid the remaining $100 million principal amount outstanding under such term loan.
	Note payable to Contran - As discussed above, in February 2013 we entered into a promissory note with Contran. This loan from Contran contained terms and conditions similar to the terms and conditions of our prior $400 million term loan, except that the loan from Contran was unsecured and contained no ongoing financial maintenance covenant. The independent members of our board of directors approved the terms and conditions of the loan from Contran. As discussed above, in February 2014 we used $170 million of the proceeds from our new term loan and prepaid the remaining balance owed to Contran under this note payable (without penalty), and the note payable to Contran was cancelled.  The average interest rate on these borrowings for the year-to-date period ended February 18, 2014 (the payoff date) was 7.375%.
	European revolving credit facility - During the first nine months of 2014, we had no borrowings or repayments under our European revolving credit facility. There were no borrowings outstanding at September 30, 2014.  Our European revolving credit facility requires the maintenance of certain financial ratios, and one of such requirements is based on the ratio of net debt to last twelve months earnings before income tax, interest, depreciation and amortization expense (EBITDA) of the borrowers. At September 30, 2013, and based on the net debt to EBITDA of the borrowers, we would not have met this financial covenant test if the borrowers had any net debt outstanding. In December 2013, the lenders under our European revolving credit facility granted a waiver through June 30, 2014 with respect to the net debt to EBITDA financial test, but our ability to borrow any amounts under the facility was subject to the requirement that the borrowers maintain a specified minimum level of EBITDA. We met the specified minimum level of EBITDA during the waiver period that ended June 30, 2014. Based upon the borrowers’ last twelve months EBITDA as of September 30, 2014 and the net debt to EBITDA financial test, our borrowing availability at September 30, 2014 is approximately 53% of the credit facility, or €64 million ($81 million).
	Revolving North American credit facility - During the first nine months of 2014, we borrowed $81.0 million and repaid $92.1 million under our North American revolving credit facility. The average interest rate on outstanding borrowings for the year-to-date period ended February 18, 2014 when the outstanding balance was repaid was 3.75%. At September 30, 2014 we had approximately $97 million available for borrowing under this revolving facility.
	Canada - At September 30, 2014, an aggregate of Cdn. $.3 million letters of credit were outstanding under our Canadian subsidiary’s loan agreement with the Bank of Montreal which exists solely for the issuance of up to Cdn. $10.0 million in letters of credit.  During the second quarter of 2014, letters of credit aggregating Cdn. $7.6 million, issued in connection with the appeal of a Canadian income tax assessment, were cancelled (see Note 8) and an equivalent amount of restricted cash deposits at the Bank of Montreal collateralizing such letters of credit, classified as noncurrent restricted cash, were released (see Note 5).
	In September 2014, we borrowed an additional Cdn. $1.2 million under our Canadian subsidiary’s agreement with an economic development agency of the Province of Quebec, Canada.  At September 30, 2014, an aggregate Cdn. $3.0 million (USD $2.7 million) was outstanding under this agreement.  Borrowings under this agreement are non-interest bearing.
	Restrictions and other - Our European credit facility described above requires the borrower to maintain minimum levels of equity, requires the maintenance of certain financial ratios, limits dividends and additional indebtedness and contains other provisions and restrictive covenants customary in lending transactions of this type. Our term loan and North American revolving credit facility also contain restrictive covenants. At September 30, 2014, there were no restrictions on our ability to pay dividends.
	We are in compliance with all of our debt covenants at September 30, 2014.

Income_Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Income Taxes	'
	Note 8 - Income taxes:
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35%	$	(15.3	)	$	15.5		$	(54.7	)	$	37.2
	Non-U.S. tax rates		0.7			(1.3	)		3.2			(3.1	)
	Incremental net tax benefit on earnings and losses of non-U.S. companies		1.3			(1.5	)		(3.4	)		(2.8	)
	Adjustment to the reserve for uncertain tax positions, net		-			0.4			1.5			(5.1	)
	Refund of prior year tax		-			(2.0	)		-			(2.0	)
	U.S. state income taxes and other, net		(.3	)		1.2			2.1			2.8
	Total	$	(13.6	)	$	12.3		$	(51.3	)	$	27
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Comprehensive provision for income taxes (benefit) allocable to:
	Net income (loss)	$	(13.6	)	$	12.3		$	(51.3	)	$	27
	Other comprehensive income (loss):
	Marketable securities		3.8			-			4.5			(6.7	)
	Currency translation		4.1			(8.9	)		2.8			(10.5	)
	Pension plans		1.1			0.8			3.3			2.6
	OPEB plans		-			-			(.1	)		(.1	)
	Total	$	(4.6	)	$	4.2		$	(40.8	)	$	12.3
	Tax authorities are examining certain of our U.S. and non-U.S. tax returns and have or may propose tax deficiencies, including penalties and interest.  Because of the inherent uncertainties involved in settlement initiatives and court and tax proceedings, we cannot guarantee that these matters will be resolved in our favor, and therefore our potential exposure, if any, is also uncertain.  We believe we have adequate accruals for additional taxes and related interest expense which could ultimately result from tax examinations.  We believe the ultimate disposition of tax examinations should not have a material adverse effect on our consolidated financial position, results of operations or liquidity.  We currently estimate that our unrecognized tax benefits will not change materially during the next twelve months.
	In 2011 and 2012, we received notices of re-assessment from the Canadian federal and provincial tax authorities related to the years 2002 through 2004.  We objected to the re-assessments and believed the position was without merit.  Accordingly, we appealed the re-assessments and in connection with such appeal we were required to post letters of credit aggregating Cdn. $7.9 million (see Note 7).  In the second quarter of 2014, the Appeals Division of the Canadian Revenue Authority ruled in our favor and reversed in their entirety such notices of re-assessment.  As a result, we recognized a non-cash income tax benefit of $3.0 million related to the release of a portion of our reserve for uncertain tax positions in the second quarter of 2014 related to the completion of this Canadian income tax audit.  In addition, related letters of credit aggregating Cdn. $7.6 million have been cancelled (see Note 7), and we anticipate the remaining Cdn. $.3 million will be cancelled by year end.  Also during the second quarter of 2014, we recognized a non-cash income tax benefit of $3.1 million related to the release of a portion of our reserve for uncertain tax positions in conjunction with the completion of an audit of our U.S. income tax return for 2009.
	Our provision for income taxes in the third quarter of 2014 includes a $2 million cash tax benefit associated with certain U.S. income tax credits, which we elected to claim on our 2012 amended tax return filed in the third quarter of 2014.

Employee_Benefit_Plans

Employee Benefit Plans	9 Months Ended
	Sep. 30, 2014
Compensation And Retirement Disclosure [Abstract]	'
Employee Benefit Plans	'
	Note 9 - Employee benefit plans:
	Defined benefit plans - The components of net periodic defined benefit pension cost are presented in the table below.
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Service cost	$	3.2		$	2.5		$	9.7		$	7.6
	Interest cost		5.4			5.7			16.2			17.1
	Expected return on plan assets		(4.9	)		(5.3	)		(14.9	)		(16.1	)
	Amortization of prior service cost		0.4			0.2			1.2			0.6
	Amortization of net transition obligations		0.1			-			0.3			-
	Recognized actuarial losses		3.1			2.5			9.3			7.7
	Total	$	7.3		$	5.6		$	21.8		$	16.9
	Postretirement benefits - The components of net periodic postretirement benefits other than pension (OPEB) cost are presented in the table below.
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Service cost	$	0.1		$	-		$	0.3		$	0.1
	Interest cost		0.2			0.1			0.4			0.3
	Amortization of prior service credit		(.2	)		(.2	)		(.5	)		(.7	)
	Recognized actuarial loss		0.1			0.1			0.3			0.2
	Total	$	0.2		$	-		$	0.5		$	(.1	)
	Contributions - We expect our 2014 contributions for our pension and other postretirement plans to be approximately $24 million.

Other_Noncurrent_Liabilities

Other Noncurrent Liabilities	9 Months Ended
	Sep. 30, 2014
Other Liabilities Disclosure [Abstract]	'
Other Noncurrent Liabilities	'
	Note 10 - Other noncurrent liabilities:
		December 31,		September 30,
		2013		2014
		(In millions)
	Reserve for uncertain tax positions	$	16.5	$	13.9
	Employee benefits		12.2		11
	Other		5.8		5.6
	Total	$	34.5	$	30.5

Accumulated_Other_Comprehensiv

Accumulated Other Comprehensive Loss	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Accumulated Other Comprehensive Loss	'
	Note 11 - Accumulated other comprehensive loss:
	Changes in accumulated other comprehensive loss for the three and nine months ended September 30, 2013 and 2014 are presented in the table below.
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Accumulated other comprehensive loss, net of tax:
	Marketable securities:
	Balance at beginning of period	$	5.4		$	(2.4	)	$	4.2		$	10.8
	Other comprehensive income (loss) -		8.2			-			9.4			(13.2	)
	unrealized gains (losses) arising during the year
	Balance at end of period	$	13.6		$	(2.4	)	$	13.6		$	(2.4	)
	Currency translation:
	Balance at beginning of period	$	(85.1	)	$	(63.7	)	$	(63.5	)	$	(56.8	)
	Other comprehensive income (loss)		21			(46.7	)		(.6	)		(53.6	)
	Balance at end of period	$	(64.1	)	$	(110.4	)	$	(64.1	)	$	(110.4	)
	Defined benefit pension plans:
	Balance at beginning of period	$	(132.3	)	$	(105.6	)	$	(137.3	)	$	(109.4	)
	Other comprehensive income -		2.4			1.9			7.4			5.7
	amortization of prior service cost and net losses
	included in net periodic pension cost
	Balance at end of period	$	(129.9	)	$	(103.7	)	$	(129.9	)	$	(103.7	)
	OPEB plans:
	Balance at beginning of period	$	(.6	)	$	3.2		$	(.5	)	$	3.4
	Other comprehensive loss -		-			(.2	)		(.1	)		(.4	)
	amortization of prior service credit and net losses
	included in net periodic OPEB cost
	Balance at end of period	$	(.6	)	$	3		$	(.6	)	$	3
	Total accumulated other comprehensive loss:
	Balance at beginning of period	$	(212.6	)	$	(168.5	)	$	(197.1	)	$	(152.0	)
	Other comprehensive income (loss)		31.6			(45.0	)		16.1			(61.5	)
	Balance at end of period	$	(181.0	)	$	(213.5	)	$	(181.0	)	$	(213.5	)
	See Note 9 for amounts related to our defined benefit pension plans and OPEB plans.

Commitments_and_Contingencies

Commitments and Contingencies	9 Months Ended
	Sep. 30, 2014
Commitments And Contingencies Disclosure [Abstract]	'
Commitments and Contingencies	'
	Note 12 - Commitments and contingencies:
	From time-to-time, we are involved in various environmental, contractual, product liability, patent (or intellectual property), employment and other claims and disputes incidental to our operations. In certain cases, we have insurance coverage for these items. We currently believe the disposition of all claims and disputes, individually or in the aggregate, should not have a material adverse effect on our consolidated financial position, results of operations or liquidity beyond the accruals we have already provided.
	Please refer to our 2013 Annual Report for a discussion of certain other legal proceedings to which we are a party.

Financial_Instruments

Financial Instruments	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Financial Instruments	'
	Note 13 - Financial instruments:
	The following table summarizes the valuation of our financial instruments recorded on a fair value basis as of December 31, 2013 and September 30, 2014:
			Fair Value Measurements
							Quoted				Significant
							prices in				other			Significant
							active				observable			unobservable
							markets				inputs			inputs
			Total				(Level 1)				(Level 2)			(Level 3)
							(In millions)
	Asset (liability)
	31-Dec-13
	Currency forward contracts		$	(1.0	)		$	(1.0	)		$	-		$	-
	Noncurrent marketable securities (See Note 4)			30.4				30.4				-			-
	30-Sep-14
	Currency forward contracts		$	0.6			$	0.6			$	-		$	-
	Noncurrent marketable securities (See Note 4)			11.3				11.3				-			-
	Certain of our sales generated by our non-U.S. operations are denominated in U.S. dollars. We periodically use currency forward contracts to manage a very nominal portion of currency exchange rate risk associated with trade receivables denominated in a currency other than the holder’s functional currency or similar exchange rate risk associated with future sales. We have not entered into these contracts for trading or speculative purposes in the past, nor do we currently anticipate entering into such contracts for trading or speculative purposes in the future. Derivatives used to hedge forecasted transactions and specific cash flows associated with financial assets and liabilities denominated in currencies other than the U.S. dollar and which meet the criteria for hedge accounting are designated as cash flow hedges. Consequently, the effective portion of gains and losses is deferred as a component of accumulated other comprehensive income and is recognized in earnings at the time the hedged item affects earnings. Contracts that do not meet the criteria for hedge accounting are marked-to-market at each balance sheet date with any resulting gain or loss recognized in income currently as part of net currency transactions. The fair value of the currency forward contracts is determined using Level 1 inputs based on the currency spot forward rates quoted by banks or currency dealers.
	At September 30, 2014, we had currency forward contracts to exchange:
	—	an aggregate of $9.0 million for an equivalent value of Canadian dollars at an exchange rate of Cdn. $1.06 per U.S. dollar. These contracts with Wells Fargo Bank, N.A. mature from October 2014 through December 2014 at a rate of $3.0 million per month, subject to early redemption provisions at our option;
	—	an aggregate €25.0 million for an equivalent value of Norwegian kroner at exchange rates ranging from kroner 8.38 to kroner 8.56 per euro. These contracts with DnB Nor Bank ASA mature at a rate of €5.0 million per quarter from December 2014 through December 2015.
	The estimated fair value of our currency forward contracts at September 30, 2014 was a $.6 million net asset, of which $1.1 million is recognized as part of accounts and other receivables and $.5 million is recognized as part of accounts payable and accrued liabilities in our Condensed Consolidated Balance Sheet. There is also a corresponding net $.6 million currency transaction gain recognized in our Condensed Consolidated Statement of Operations. We are not currently using hedge accounting for our outstanding currency forward contracts at September 30, 2014, and we did not use hedge accounting for any of such contracts we previously held in 2013.
	The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure as of December 31, 2013 and September 30, 2014.
		31-Dec-13								30-Sep-14
		Carrying amount				Fair				Carrying amount			Fair
						value							value
		(In millions)
	Cash, cash equivalents and restricted cash	$	63.8			$	63.8			$	153.5		$	153.5
	Notes payable and long-term debt:
	Variable rate:
	Term loan		-				-				346.7			343.9
	Note payable to Contran		170				170				-			-
	North American credit facility		11.1				11.1				-			-
	Common stockholders' equity		935.1				2,207.20				900.9			1,596.70
	At September 30, 2014, the estimated market price of our term loan was $987.50 per $1,000 principal amount. The fair value of our term loan is based on quoted market prices; however, these quoted market prices represent Level 2 inputs because the markets in which the term loan trades were not active. The fair values of our note payable to Contran and our European credit facility represent Level 2 inputs, and are deemed to approximate book value. The fair value of our common stockholders’ equity is based upon quoted market prices at each balance sheet date, which represent Level 1 inputs. Due to their near-term maturities, the carrying amounts of accounts receivable and accounts payable are considered equivalent to fair value.

Recent_Accounting_Pronouncemen

Recent Accounting Pronouncements	9 Months Ended
	Sep. 30, 2014
New Accounting Pronouncements And Changes In Accounting Principles [Abstract]	'
Recent Accounting Pronouncements	'
	Note 14 - Recent accounting pronouncements:
	In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606).  This standard replaces existing revenue recognition guidance, which in many cases was tailored for specific industries, with a uniform accounting standard applicable to all industries and transactions.  The new standard is effective for us beginning with the first quarter of 2017.  Entities may elect to adopt ASU No. 2014-09 retrospectively for all periods for all contracts and transactions which occurred during the period (with a few exceptions for practical expediency) or retrospectively with a cumulative effect recognized as of the date of adoption.  ASU No. 2014-09 is a fundamental rewriting of existing GAAP with respect to revenue recognition, and we are still evaluating the effect the Standard will have on our Consolidated Financial Statements.  In addition, we have not yet determined the method we will use to adopt the Standard.

Organization_and_Basis_of_Pres1

Organization and Basis of Presentation (Policies)	9 Months Ended
	Sep. 30, 2014
Organization Consolidation And Presentation Of Financial Statements [Abstract]	'
Organization	'
	Organization - At September 30, 2014, (i) Valhi, Inc. (NYSE: VHI) held approximately 50% of our outstanding common stock (ii) NL Industries, Inc. (NYSE: NL) held approximately 30% of our common stock, (iii) Valhi owned approximately 83% of NL’s outstanding common stock and (iv) a wholly-owned subsidiary of Contran Corporation held approximately 94% of Valhi’s outstanding common stock.  Substantially all of Contran’s outstanding voting stock is held by family trusts established for the benefit of Lisa K. Simmons and Serena Simmons Connelly, daughters of Harold C. Simmons, and their children (for which Ms. Lisa Simmons and Ms. Connelly are co-trustees) or is held directly by Ms. Lisa Simmons and Ms. Connelly or persons or entities related to them, including their step-mother Annette C. Simmons, the widow of Mr. Simmons. Prior to his death in December 2013, Mr. Simmons served as sole trustee of the family trusts.  Under a voting agreement entered into by all of the voting stockholders of Contran, effective in February 2014 and as amended, the size of the board of directors of Contran was fixed at five members, Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons (and in the event of their death, their heirs) each has the right to designate one of the five members of the Contran board and the remaining two members of the Contran board must consist of members of Contran management. Ms. Lisa Simmons, Ms. Connelly, and Ms. Annette Simmons each serve as members of the Contran board.  The voting agreement expires in February 2017 (unless Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons otherwise unanimously agree), and the ability of Ms. Lisa Simmons, Ms. Connelly, and Ms. Annette Simmons to each designate one member of the Contran board is dependent upon each of their continued beneficial ownership of at least 5% of the combined voting stock of Contran.  Consequently, Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons may be deemed to control Contran, Valhi, NL and us.
Basis of Presentation	'
	Basis of presentation - The unaudited Condensed Consolidated Financial Statements contained in this Quarterly Report have been prepared on the same basis as the audited Consolidated Financial Statements in our Annual Report on Form 10-K for the year ended December 31, 2013 that we filed with the Securities and Exchange Commission (SEC) on March 12, 2014 (2013 Annual Report).  In our opinion, we have made all necessary adjustments (which include only normal recurring adjustments) in order to state fairly, in all material respects, our consolidated financial position, results of operations and cash flows as of the dates and for the periods presented.  We have condensed the Consolidated Balance Sheet and Statement of Stockholders’ Equity at December 31, 2013 contained in this Quarterly Report as compared to our audited Consolidated Financial Statements at that date, and we have omitted certain information and footnote disclosures (including those related to the Consolidated Balance Sheet at December 31, 2013) normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP).  Our results of operations for the interim periods ended September 30, 2014 may not be indicative of our operating results for the full year.  The Condensed Consolidated Financial Statements contained in this Quarterly Report should be read in conjunction with our 2013 Consolidated Financial Statements contained in our 2013 Annual Report.
New Accounting Pronouncements, Policy	'
	In May 2014, the Financial Accounting Standards Board issued Accounting Standards Update (ASU) No. 2014-09, Revenue from Contracts with Customers (Topic 606).  This standard replaces existing revenue recognition guidance, which in many cases was tailored for specific industries, with a uniform accounting standard applicable to all industries and transactions.  The new standard is effective for us beginning with the first quarter of 2017.  Entities may elect to adopt ASU No. 2014-09 retrospectively for all periods for all contracts and transactions which occurred during the period (with a few exceptions for practical expediency) or retrospectively with a cumulative effect recognized as of the date of adoption.  ASU No. 2014-09 is a fundamental rewriting of existing GAAP with respect to revenue recognition, and we are still evaluating the effect the Standard will have on our Consolidated Financial Statements.  In addition, we have not yet determined the method we will use to adopt the Standard.

Accounts_and_Other_Receivables1

Accounts and Other Receivables (Tables)	9 Months Ended
	Sep. 30, 2014
Receivables [Abstract]	'
Accounts and Other Receivables	'
		December 31,			September 30,
		2013			2014
		(In millions)
	Trade receivables	$	226.1		$	288.4
	Receivable from affiliates:
	Louisiana Pigment Company, L.P.		14.2			-
	Income taxes, net - Valhi		-			5.8
	Other		-			1.2
	Recoverable VAT and other receivables		28.3			27.6
	Refundable income taxes		14.9			7.9
	Allowance for doubtful accounts		(1.0	)		(1.0	)
	Total	$	282.5		$	329.9

Inventories_Net_Tables

Inventories, Net (Tables)	9 Months Ended
	Sep. 30, 2014
Inventory Disclosure [Abstract]	'
Schedule of Inventories, Net	'
		December 31,		September 30,
		2013		2014
		(In millions)
	Raw materials	$	66.6	$	62.2
	Work in process		18		28.6
	Finished products		262.6		242.1
	Supplies		69.4		66.7
	Total	$	416.6	$	399.6

Marketable_Securities_Tables

Marketable Securities (Tables)	9 Months Ended
	Sep. 30, 2014
Investments Debt And Equity Securities [Abstract]	'
Classification of Marketable Securities	'
		Fair value
		measurement	Market		Cost		Unrealized
	Marketable security	level	value		basis		gain (loss)
			(In millions)
	31-Dec-13
	Valhi common stock	1	$	30.3	$	15.3	$	15
	NL and CompX common stocks	1		0.1		0.1		-
	Total		$	30.4	$	15.4	$	15
	30-Sep-14
	Valhi common stock	1	$	11.2	$	15.3	$	(4.1	)
	NL and CompX common stocks	1		0.1		0.1		-
	Total		$	11.3	$	15.4	$	(4.1	)

Other_Noncurrent_Assets_Tables

Other Noncurrent Assets (Tables)	9 Months Ended
	Sep. 30, 2014
Assets Noncurrent [Abstract]	'
Schedule of Other Noncurrent Assets	'
		December 31,		September 30,
		2013		2014
		(In millions)
	Deferred financing costs, net	$	2.5	$	7.2
	Restricted cash		7.4		0.3
	Pension asset		0.2		0.4
	Other		10.4		8.9
	Total	$	20.5	$	16.8

Accounts_Payable_and_Accrued_L1

Accounts Payable and Accrued Liabilities (Tables)	9 Months Ended
	Sep. 30, 2014
Payables And Accruals [Abstract]	'
Components of Accounts Payable and Accrued Liabilities	'
		December 31,		September 30,
		2013		2014
		(In millions)
	Accounts payable	$	123.9	$	105.1
	Employee benefits		26.7		29.5
	Accrued sales discounts and rebates		16.7		19.5
	Reserve for uncertain tax positions		3.1		-
	Accrued interest		0.1		0.5
	Accrued legal settlement		35		-
	Payables to affiliates:
	Louisiana Pigment Company, L.P.		21.1		15.3
	Income taxes, net - Valhi		0.5		-
	Other		0.1		-
	Other		36.8		35.3
	Total	$	264	$	205.2

LongTerm_Debt_Tables

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2014
Debt Disclosure [Abstract]	'
Components of Long Term Debt	'
		December 31,		September 30,
		2013		2014
		(In millions)
	Term loan	$	-	$	346.7
	Note payable to Contran		170		-
	Revolving North American credit facility		11.1		-
	Other		2.4		2.9
	Total debt		183.5		349.6
	Less current maturities		3.1		3.9
	Total long-term debt	$	180.4	$	345.7

Income_Taxes_Tables

Income Taxes (Tables)	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
Components of Income Taxes	'
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35%	$	(15.3	)	$	15.5		$	(54.7	)	$	37.2
	Non-U.S. tax rates		0.7			(1.3	)		3.2			(3.1	)
	Incremental net tax benefit on earnings and losses of non-U.S. companies		1.3			(1.5	)		(3.4	)		(2.8	)
	Adjustment to the reserve for uncertain tax positions, net		-			0.4			1.5			(5.1	)
	Refund of prior year tax		-			(2.0	)		-			(2.0	)
	U.S. state income taxes and other, net		(.3	)		1.2			2.1			2.8
	Total	$	(13.6	)	$	12.3		$	(51.3	)	$	27
Components of Comprehensive Provision for Income Taxes Allocation	'
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Comprehensive provision for income taxes (benefit) allocable to:
	Net income (loss)	$	(13.6	)	$	12.3		$	(51.3	)	$	27
	Other comprehensive income (loss):
	Marketable securities		3.8			-			4.5			(6.7	)
	Currency translation		4.1			(8.9	)		2.8			(10.5	)
	Pension plans		1.1			0.8			3.3			2.6
	OPEB plans		-			-			(.1	)		(.1	)
	Total	$	(4.6	)	$	4.2		$	(40.8	)	$	12.3

Employee_Benefit_Plans_Tables

Employee Benefit Plans (Tables)	9 Months Ended
	Sep. 30, 2014
Defined Benefit Pension Plans	'
Components of Net Periodic Benefit Cost	'
	Defined benefit plans - The components of net periodic defined benefit pension cost are presented in the table below.
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Service cost	$	3.2		$	2.5		$	9.7		$	7.6
	Interest cost		5.4			5.7			16.2			17.1
	Expected return on plan assets		(4.9	)		(5.3	)		(14.9	)		(16.1	)
	Amortization of prior service cost		0.4			0.2			1.2			0.6
	Amortization of net transition obligations		0.1			-			0.3			-
	Recognized actuarial losses		3.1			2.5			9.3			7.7
	Total	$	7.3		$	5.6		$	21.8		$	16.9
OPEB	'
Components of Net Periodic Benefit Cost	'
	Postretirement benefits - The components of net periodic postretirement benefits other than pension (OPEB) cost are presented in the table below.
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Service cost	$	0.1		$	-		$	0.3		$	0.1
	Interest cost		0.2			0.1			0.4			0.3
	Amortization of prior service credit		(.2	)		(.2	)		(.5	)		(.7	)
	Recognized actuarial loss		0.1			0.1			0.3			0.2
	Total	$	0.2		$	-		$	0.5		$	(.1	)

Other_Noncurrent_Liabilities_T

Other Noncurrent Liabilities (Tables)	9 Months Ended
	Sep. 30, 2014
Other Liabilities Disclosure [Abstract]	'
Other Noncurrent Liabilities	'
		December 31,		September 30,
		2013		2014
		(In millions)
	Reserve for uncertain tax positions	$	16.5	$	13.9
	Employee benefits		12.2		11
	Other		5.8		5.6
	Total	$	34.5	$	30.5

Accumulated_Other_Comprehensiv1

Accumulated Other Comprehensive Coss (Tables)	9 Months Ended
	Sep. 30, 2014
Equity [Abstract]	'
Schedule of Changes in Accumulated Other Comprehensive Loss	'
	Changes in accumulated other comprehensive loss for the three and nine months ended September 30, 2013 and 2014 are presented in the table below.
		Three months ended						Nine months ended
		September 30,						September 30,
		2013			2014			2013			2014
		(In millions)
	Accumulated other comprehensive loss, net of tax:
	Marketable securities:
	Balance at beginning of period	$	5.4		$	(2.4	)	$	4.2		$	10.8
	Other comprehensive income (loss) -		8.2			-			9.4			(13.2	)
	unrealized gains (losses) arising during the year
	Balance at end of period	$	13.6		$	(2.4	)	$	13.6		$	(2.4	)
	Currency translation:
	Balance at beginning of period	$	(85.1	)	$	(63.7	)	$	(63.5	)	$	(56.8	)
	Other comprehensive income (loss)		21			(46.7	)		(.6	)		(53.6	)
	Balance at end of period	$	(64.1	)	$	(110.4	)	$	(64.1	)	$	(110.4	)
	Defined benefit pension plans:
	Balance at beginning of period	$	(132.3	)	$	(105.6	)	$	(137.3	)	$	(109.4	)
	Other comprehensive income -		2.4			1.9			7.4			5.7
	amortization of prior service cost and net losses
	included in net periodic pension cost
	Balance at end of period	$	(129.9	)	$	(103.7	)	$	(129.9	)	$	(103.7	)
	OPEB plans:
	Balance at beginning of period	$	(.6	)	$	3.2		$	(.5	)	$	3.4
	Other comprehensive loss -		-			(.2	)		(.1	)		(.4	)
	amortization of prior service credit and net losses
	included in net periodic OPEB cost
	Balance at end of period	$	(.6	)	$	3		$	(.6	)	$	3
	Total accumulated other comprehensive loss:
	Balance at beginning of period	$	(212.6	)	$	(168.5	)	$	(197.1	)	$	(152.0	)
	Other comprehensive income (loss)		31.6			(45.0	)		16.1			(61.5	)
	Balance at end of period	$	(181.0	)	$	(213.5	)	$	(181.0	)	$	(213.5	)

Financial_Instruments_Tables

Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2014
Fair Value Disclosures [Abstract]	'
Valuation of Financial Instruments Recorded on Fair Value Basis	'
	The following table summarizes the valuation of our financial instruments recorded on a fair value basis as of December 31, 2013 and September 30, 2014:
			Fair Value Measurements
							Quoted				Significant
							prices in				other			Significant
							active				observable			unobservable
							markets				inputs			inputs
			Total				(Level 1)				(Level 2)			(Level 3)
							(In millions)
	Asset (liability)
	31-Dec-13
	Currency forward contracts		$	(1.0	)		$	(1.0	)		$	-		$	-
	Noncurrent marketable securities (See Note 4)			30.4				30.4				-			-
	30-Sep-14
	Currency forward contracts		$	0.6			$	0.6			$	-		$	-
	Noncurrent marketable securities (See Note 4)			11.3				11.3				-			-
Financial Instruments not Carried at Fair Value but which Require Fair Value Disclosure	'
	The following table presents the financial instruments that are not carried at fair value but which require fair value disclosure as of December 31, 2013 and September 30, 2014.
		31-Dec-13								30-Sep-14
		Carrying amount				Fair				Carrying amount			Fair
						value							value
		(In millions)
	Cash, cash equivalents and restricted cash	$	63.8			$	63.8			$	153.5		$	153.5
	Notes payable and long-term debt:
	Variable rate:
	Term loan		-				-				346.7			343.9
	Note payable to Contran		170				170				-			-
	North American credit facility		11.1				11.1				-			-
	Common stockholders' equity		935.1				2,207.20				900.9			1,596.70

Organization_and_Basis_of_Pres2

Organization and Basis of Presentation - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2014
Valhi Inc	'
Organization And Basis Of Presentation [Line Items]	'
Ownership percentage in subsidiary	50.00%
Ownership percentage in company	83.00%
NL Industries Inc.	'
Organization And Basis Of Presentation [Line Items]	'
Ownership percentage in subsidiary	30.00%
Contran	'
Organization And Basis Of Presentation [Line Items]	'
Ownership percentage in company	94.00%
Controlling interest description	'Ms. Lisa Simmons, Ms. Connelly, and Ms. Annette Simmons each serve as members of the Contran board. The voting agreement expires in February 2017 (unless Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons otherwise unanimously agree), and the ability of Ms. Lisa Simmons, Ms. Connelly, and Ms. Annette Simmons to each designate one member of the Contran board is dependent upon each of their continued beneficial ownership of at least 5% of the combined voting stock of Contran. Consequently, Ms. Lisa Simmons, Ms. Connelly and Ms. Annette Simmons may be deemed to control Contran, Valhi, NL and us.
Voting agreement expiration date	'2017-02
Contran | Minimum	'
Organization And Basis Of Presentation [Line Items]	'
Beneficial ownership required percentage for combined voting stock	5.00%
Contran | Board of Directors Chairman	'
Organization And Basis Of Presentation [Line Items]	'
Number of directors	5

Accounts_and_Other_Receivables2

Accounts and Other Receivables - Accounts and Other Receivables (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Accounts Notes And Loans Receivable [Line Items]	'	'
Allowance for doubtful accounts	($1)	($1)
Total	329.9	282.5
Trade receivables	'	'
Accounts Notes And Loans Receivable [Line Items]	'	'
Accounts and other receivables	288.4	226.1
Receivable from affiliates | Louisiana Pigment Company, L.P.	'	'
Accounts Notes And Loans Receivable [Line Items]	'	'
Receivable from affiliates	'	14.2
Income taxes, net | Valhi	'	'
Accounts Notes And Loans Receivable [Line Items]	'	'
Receivable from affiliates	5.8	'
Other	'	'
Accounts Notes And Loans Receivable [Line Items]	'	'
Receivable from affiliates	1.2	'
Recoverable VAT and other receivables	'	'
Accounts Notes And Loans Receivable [Line Items]	'	'
Accounts and other receivables	27.6	28.3
Refundable income taxes	'	'
Accounts Notes And Loans Receivable [Line Items]	'	'
Refundable income taxes	$7.90	$14.90

Inventories_Net_Schedule_of_In

Inventories, Net - Schedule of Inventories, Net (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Inventory Disclosure [Abstract]	'	'
Raw materials	$62.20	$66.60
Work in process	28.6	18
Finished products	242.1	262.6
Supplies	66.7	69.4
Total	$399.60	$416.60

Marketable_Securities_Classifi

Marketable Securities - Classification of Marketable Securities (Detail) (USD $)	9 Months Ended	12 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013
Schedule Of Available For Sale Securities [Line Items]	'	'
Market value	$11.30	$30.40
Cost basis	15.4	15.4
Unrealized gain (loss)	-4.1	15
Level 1 | Common stock | Valhi	'	'
Schedule Of Available For Sale Securities [Line Items]	'	'
Market value	11.2	30.3
Cost basis	15.3	15.3
Unrealized gain (loss)	-4.1	15
Level 1 | Common stock | NL and CompX	'	'
Schedule Of Available For Sale Securities [Line Items]	'	'
Market value	0.1	0.1
Cost basis	$0.10	$0.10

Marketable_Securities_Addition

Marketable Securities - Additional Information (Detail) (USD $)	9 Months Ended	12 Months Ended			1 Months Ended
In Millions, except Per Share data, unless otherwise specified	Sep. 30, 2014	Dec. 31, 2013	Sep. 30, 2014	Dec. 31, 2013	Oct. 31, 2014
			Valhi Inc	Valhi Inc	Valhi Inc
			Common stock	Common stock	Common stock
					Subsequent Event
Schedule Of Available For Sale Securities [Line Items]	'	'	'	'	'
Outstanding common stock	'	'	1.7	1.7	'
Quoted market price of per share	'	'	$6.53	$17.58	'
Aggregate quoted market price of shares	($4.10)	$15	'	'	($5.10)

Other_Noncurrent_Assets_Schedu

Other Noncurrent Assets - Schedule of Other Noncurrent Assets (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Disclosure Other Non Current Assets Schedule Of Other Non Current Assets [Abstract]	'	'
Deferred financing costs, net	$7.20	$2.50
Restricted cash	0.3	7.4
Pension asset	0.4	0.2
Other	8.9	10.4
Total	$16.80	$20.50

Accounts_Payable_and_Accrued_L2

Accounts Payable and Accrued Liabilities - Components of Accounts Payable and Accrued Liabilities (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Accounts Payable And Accrued Liabilities [Line Items]	'	'
Accounts payable	$105.10	$123.90
Employee benefits	29.5	26.7
Accrued sales discounts and rebates	19.5	16.7
Reserve for uncertain tax positions	'	3.1
Accrued interest	0.5	0.1
Accrued legal settlement	'	35
Payables to affiliates:	'	'
Payables to affiliates	'	0.1
Other	35.3	36.8
Total	205.2	264
Louisiana Pigment Company, L.P.	'	'
Payables to affiliates:	'	'
Payables to affiliates	15.3	21.1
Valhi	'	'
Payables to affiliates:	'	'
Payables to affiliates	'	$0.50

LongTerm_Debt_Components_of_Lo

Long-Term Debt - Components of Long-Term Debt (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Debt Instrument [Line Items]	'	'
Total debt	$349.60	$183.50
Less current maturities	3.9	3.1
Long-term debt	345.7	180.4
Term loan	'	'
Debt Instrument [Line Items]	'	'
Total debt	346.7	'
Note Payable | Contran	'	'
Debt Instrument [Line Items]	'	'
Total debt	'	170
North America	'	'
Debt Instrument [Line Items]	'	'
Total debt	'	11.1
Other	'	'
Debt Instrument [Line Items]	'	'
Total debt	$2.90	$2.40

LongTerm_Debt_Term_Loan_Additi

Long-Term Debt - Term Loan - Additional Information (Detail) (USD $)

1 Months Ended

3 Months Ended

9 Months Ended

1 Months Ended

9 Months Ended

1 Months Ended

1 Months Ended

9 Months Ended

Feb. 28, 2013

Sep. 30, 2013

Sep. 30, 2013

Feb. 20, 2014

Feb. 28, 2013

Feb. 28, 2014

Sep. 30, 2014

Feb. 28, 2014

Feb. 28, 2014

Feb. 28, 2014

Feb. 28, 2014

Feb. 28, 2014

Feb. 28, 2014

Jul. 31, 2013

Feb. 28, 2013

Sep. 30, 2014

Dec. 31, 2012

Contran

Contran

New Term Loan

New Term Loan

New Term Loan

New Term Loan

New Term Loan

New Term Loan

New Term Loan

New Term Loan

Term Loan

Term Loan

Term Loan

Term Loan

U.S. wholly-owned subsidiaries

Canadian First-Tier European Subsidiaries

Kronos International, Inc

London Interbank Offered Rate (LIBOR)

Base Rate

Contran

Debt Instrument [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Payment of Principal Amount

'

'

'

'

'

'

'

'

'

'

'

'

$170,000,000

$100,000,000

$290,000,000

'

'

Debt instrument face amount

'

'

'

'

'

350,000,000

'

'

'

'

'

'

'

'

'

'

400,000,000

Principal amount percentage of loan raised

'

'

'

'

'

99.50%

'

'

'

'

'

'

'

'

'

'

'

Aggregate amount of loan issued

'

'

'

'

'

348,250,000

'

'

'

'

'

'

'

'

'

'

'

Minimum LIBOR rate

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

Debt instrument basis spread on variable rate

'

'

'

'

'

'

'

'

'

'

3.75%

2.75%

'

'

'

'

'

Quarterly principal repayments

'

'

'

'

'

875,000

'

'

'

'

'

'

'

'

'

'

'

Commencement date of quarterly principal repayments

'

'

'

'

'

30-Jun-14

'

'

'

'

'

'

'

'

'

'

'

Remaining outstanding principal maturity date

'

'

'

'

'

28-Feb-20

'

'

'

'

'

'

'

'

'

'

'

Long term debt prepayments terms

'

'

'

'

'

'

'Voluntary principal prepayments are permitted at any time, provided that a call premium of 1% of the principal amount of such prepayment applies to any voluntary prepayment made on or before February 2015 (there is no prepayment penalty applicable to any voluntary prepayment after February 2015)

'

'

'

'

'

'

'

'

'

'

Call premium percentage

'

'

'

'

'

1.00%

'

'

'

'

'

'

'

'

'

'

'

Voluntary prepayment, earliest date

'

'

'

'

'

28-Feb-15

'

'

'

'

'

'

'

'

'

'

'

Term Loan Collateralized Priority

'

'

'

'

'

'

'

100.00%

65.00%

'

'

'

'

'

'

'

'

Loan pledged as collateral from wholly-owned subsidiary

'

'

'

'

'

'

'

'

'

395,700,000

'

'

'

'

'

'

'

Minimum amount of debt default for using customary default provisions

'

'

'

'

'

50,000,000

'

'

'

'

'

'

'

'

'

'

'

Percentage of average interest rate, during period

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

4.75%

'

Unamortized discount balance

'

'

'

'

'

'

'

'

'

'

'

'

'

'

'

1,600,000

'

Loss on prepayment of debt, net

-6,600,000

-2,300,000

-8,900,000

'

'

'

'

'

'

'

'

'

'

'

'

'

'

Cash on hand used to repay term loan

'

'

'

'

'

'

'

'

'

'

'

'

'

'

100,000,000

'

'

Borrowing for prepayment of term loan

'

'

'

'

$190,000,000

'

'

'

'

'

'

'

'

'

'

'

'

Percentage of average interest rate

'

'

'

7.38%

'

'

'

'

'

'

'

'

'

'

'

'

'

LongTerm_Debt_Revolving_Credit

Long-Term Debt - Revolving Credit Facilities - Additional Information (Detail)	9 Months Ended			9 Months Ended	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Jun. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014
		European Revolving Credit Facility	European Revolving Credit Facility	Revolving North American Credit Facility	Bank Of Montreal	Bank Of Montreal	Economic Development Agency Credit Facility	Economic Development Agency Credit Facility
		USD ($)	EUR (€)	USD ($)	CAD	CAD	CAD	USD ($)
Line Of Credit Facility [Line Items]	'	'	'	'	'	'	'	'
Amount available for Borrowing	'	$81	€ 64	$97	'	'	'	'
Percentage of borrowings available under credit facility	'	53.00%	53.00%	'	'	'	'	'
Outstanding borrowings under this revolving credit facility	'	0	'	'	'	'	3	2.7
Borrowings under credit facility during the period	'	'	'	81	'	'	1.2	'
Repayments of lines of credit	'	'	'	92.1	'	'	'	'
Percentage of average interest rate	'	'	'	3.75%	'	'	'	'
Aggregate letter of credit outstanding amount	'	'	'	'	'	0.3	'	'
Issuance of letter of credit	'	'	'	'	'	10	'	'
Aggregate letters of credit extinguishment amount	'	'	'	'	7.6	'	'	'
Dividend restrictions	'there were no restrictions on our ability to pay dividends	'	'	'	'	'	'	'

Income_Taxes_Components_of_Inc

Income Taxes - Components of Income Taxes (Detail) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Income Tax Disclosure [Abstract]	'	'	'	'
Expected tax expense (benefit), at U.S. federal statutory income tax rate of 35%	$15.50	($15.30)	$37.20	($54.70)
Non-U.S. tax rates	-1.3	0.7	-3.1	3.2
Incremental net tax benefit on earnings and losses of non-U.S. companies	-1.5	1.3	-2.8	-3.4
Adjustment to the reserve for uncertain tax positions, net	0.4	'	-5.1	1.5
Refund of prior year tax	-2	'	-2	'
U.S. state income taxes and other, net	1.2	-0.3	2.8	2.1
Total	$12.30	($13.60)	$27	($51.30)

Income_Taxes_Components_of_Inc1

Income Taxes - Components of Income Taxes (Parenthetical) (Detail)	9 Months Ended
	Sep. 30, 2014
Income Tax Disclosure [Abstract]	'
U.S. Federal statutory income tax rate	35.00%

Income_Taxes_Components_of_Com

Income Taxes - Components of Comprehensive Provision for Income Taxes Allocation (Detail) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Schedule Of Income Tax [Line Items]	'	'	'	'
Net income (loss)	$12.30	($13.60)	$27	($51.30)
Other comprehensive income (loss):	'	'	'	'
Marketable securities	'	3.8	-6.7	4.5
Currency translation	-8.9	4.1	-10.5	2.8
Total	4.2	-4.6	12.3	-40.8
Defined Benefit Pension Plans	'	'	'	'
Other comprehensive income (loss):	'	'	'	'
Benefit plans	0.8	1.1	2.6	3.3
OPEB	'	'	'	'
Other comprehensive income (loss):	'	'	'	'
Benefit plans	'	'	($0.10)	($0.10)

Income_Taxes_Additional_Inform

Income Taxes - Additional Information (Detail)	0 Months Ended	3 Months Ended	6 Months Ended	9 Months Ended	3 Months Ended
In Millions, unless otherwise specified	Aug. 05, 2014	Sep. 30, 2014	Jun. 30, 2014	Sep. 30, 2014	Jun. 30, 2014	Jun. 30, 2014
	CAD	USD ($)	CAD	USD ($)	Canadian Income Tax Audit	U.S. Income Tax Audit
					USD ($)	USD ($)
Income Tax [Line Items]	'	'	'	'	'	'
Aggregate letter of credit outstanding amount	'	'	7.9	'	'	'
Non-cash income tax benefit recognized related to release of portion of reserve for uncertain tax positions	'	'	'	'	-3	-3.1
Aggregate letters of credit extinguishment amount	0.3	'	7.6	'	'	'
Cash tax benefit associated with U.S. income tax credits	'	($2)	'	($2)	'	'

Employee_Benefit_Plans_Compone

Employee Benefit Plans - Components of Net Periodic Benefit Cost (Detail) (USD $)	3 Months Ended		9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014	Sep. 30, 2013	Sep. 30, 2014	Sep. 30, 2013
Defined Benefit Pension Plans	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	$2.50	$3.20	$7.60	$9.70
Interest cost	5.7	5.4	17.1	16.2
Expected return on plan assets	-5.3	-4.9	-16.1	-14.9
Amortization of prior service cost	0.2	0.4	0.6	1.2
Amortization of net transition obligations	'	0.1	'	0.3
Recognized actuarial losses	2.5	3.1	7.7	9.3
Total	5.6	7.3	16.9	21.8
OPEB	'	'	'	'
Defined Benefit Plan Disclosure [Line Items]	'	'	'	'
Service cost	'	0.1	0.1	0.3
Interest cost	0.1	0.2	0.3	0.4
Amortization of prior service cost	-0.2	-0.2	-0.7	-0.5
Recognized actuarial losses	0.1	0.1	0.2	0.3
Total	'	$0.20	($0.10)	$0.50

Employee_Benefit_Plans_Additio

Employee Benefit Plans - Additional Information (Detail) (USD $)	9 Months Ended
In Millions, unless otherwise specified	Sep. 30, 2014
Compensation And Retirement Disclosure [Abstract]	'
Expected contributions for pension plans in 2014	$24

Other_Noncurrent_Liabilities_C

Other Noncurrent Liabilities - Components of Other Noncurrent Liabilities (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Other Liabilities Noncurrent [Abstract]	'	'
Reserve for uncertain tax positions	$13.90	$16.50
Employee benefits	11	12.2
Other	5.6	5.8
Total	$30.50	$34.50

Accumulated_Other_Comprehensiv2

Accumulated Other Comprehensive Loss - Changes In Accumulated Other Comprehensive Loss (Detail) (USD $)

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

3 Months Ended

9 Months Ended

In Millions, unless otherwise specified

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2013

Sep. 30, 2014

Sep. 30, 2014

Sep. 30, 2013

Jun. 30, 2013

Defined Benefit Pension Plans

Defined Benefit Pension Plans

Defined Benefit Pension Plans

Defined Benefit Pension Plans

OPEB Plans

OPEB Plans

OPEB Plans

OPEB Plans

Accumulated Other Comprehensive Income Loss [Line Items]

'

'

'

'

'

'

'

'

'

'

'

'

Marketable securities, Balance at beginning of period

($2.40)

$5.40

$10.80

$4.20

'

'

'

'

'

'

'

'

Other comprehensive income (loss) - unrealized gains (losses) arising during the year

'

8.2

-13.2

9.4

'

'

'

'

'

'

'

'

Marketable securities, Balance at end of period

-2.4

13.6

-2.4

13.6

'

'

'

'

'

'

'

'

Currency translation, Balance at beginning of period

-63.7

-85.1

-56.8

-63.5

'

'

'

'

'

'

'

'

Other comprehensive income (loss)

-46.7

21

-53.6

-0.6

'

'

'

'

'

'

'

'

Currency translation, Balance at end of period

-110.4

-64.1

-110.4

-64.1

'

'

'

'

'

'

'

'

Balance at beginning of period

'

'

'

'

-105.6

-132.3

-109.4

-137.3

3.2

3.4

-0.5

-0.6

Other comprehensive income - amortization of prior service cost and net losses included in net periodic pension cost

'

'

'

'

1.9

2.4

5.7

7.4

-0.2

-0.4

-0.1

'

Balance at end of period

'

'

'

'

-103.7

-129.9

-103.7

-129.9

3

3

-0.6

-0.6

Balance at beginning of period

-168.5

-212.6

-152

-197.1

'

'

'

'

'

'

'

'

Other comprehensive income (loss)

-45

31.6

-61.5

16.1

'

'

'

'

'

'

'

'

Balance at end of period

($213.50)

($181)

($213.50)

($181)

'

'

'

'

'

'

'

'

Financial_Instruments_Valuatio

Financial Instruments - Valuation of Financial Instruments Recorded on Fair Value Basis (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]	'	'
Noncurrent marketable securities	$11.30	$30.40
Fair Value Measurements Recurring	'	'
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]	'	'
Currency forward contracts	0.6	-1
Noncurrent marketable securities	11.3	30.4
Fair Value Measurements Recurring | Level 1	'	'
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]	'	'
Currency forward contracts	0.6	-1
Noncurrent marketable securities	$11.30	$30.40

Financial_Instruments_Addition

Financial Instruments - Additional Information (Detail)	9 Months Ended
	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014	Sep. 30, 2014
	USD ($)	Foreign Exchange Contract	Wells Fargo Bank, NA	DnB Nor Bank ASA	DnB Nor Bank ASA	DnB Nor Bank ASA
		USD ($)	USD ($)	EUR (€)	Minimum	Maximum
					Euros	Euros
Derivative [Line Items]	'	'	'	'	'	'
Forward currency contracts aggregate exchange value	'	'	$9,000,000	€ 25,000,000	'	'
Forward currency contracts, exchange rate	'	'	1.06	'	8.38	8.56
Foreign currency contracts maturing value	'	'	3,000,000	5,000,000	'	'
Estimated fair value of currency forward contracts net asset	'	600,000	'	'	'	'
Estimated fair value of currency forward contracts included accounts and other receivables	1,100,000	'	'	'	'	'
Estimated fair value of currency forward contracts included accounts payable and accrued liabilities	500,000	'	'	'	'	'
Currency transaction gain	600,000	'	'	'	'	'
Debt instrument base principal amount	1,000	'	'	'	'	'
Debt instrument estimated market price per principal amount	$987.50	'	'	'	'	'

Financial_Instruments_Financia

Financial Instruments - Financial Instruments not Carried at Fair Value but which Require Fair Value Disclosure (Detail) (USD $)	Sep. 30, 2014	Dec. 31, 2013
In Millions, unless otherwise specified
Carrying Amount	'	'
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]	'	'
Cash, cash equivalents and restricted cash	$153.50	$63.80
Term loan	346.7	'
North American credit facility	'	11.1
Common stockholders' equity	900.9	935.1
Fair Value	'	'
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]	'	'
Cash, cash equivalents and restricted cash	153.5	63.8
Term loan	343.9	'
North American credit facility	'	11.1
Common stockholders' equity	1,596.70	2,207.20
Contran | Carrying Amount	'	'
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]	'	'
Note payable to Contran	'	170
Contran | Fair Value	'	'
Fair Value Balance Sheet Grouping Financial Statement Captions [Line Items]	'	'
Note payable to Contran	'	$170